Clinical-stage biopharmaceutical company Neurotech International has appointed Carolyn Ellaway as its chief medical officer, effective from August 1.

Clinical-stage biopharmaceutical company Neurotech International has appointed Carolyn Ellaway as its chief medical officer, effective from August 1.